טוען...
Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPD
The basic leucine zipper transcription factor ATF5 is over-expressed in many tumor types and interference with its expression or function inhibits cancer cell survival. As a potential therapeutic approach to exploit these findings, we created dominant-negative (DN) ATF5 forms lacking DNA-binding abi...
שמור ב:
| הוצא לאור ב: | Mol Cancer Res |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7561279/ https://ncbi.nlm.nih.gov/pubmed/31676720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-19-0631 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|